An oxidative stress in the form of H2O2 exposure previously has been shown to cause a transient increase in NO??oduction and a chronic increase in eNOS protein levels. Nevertheless, oxidative stress can cause an uncoupling of catalytic activity resulting in decreased NO??d increased O2??roduction from eNOS. This uncoupling seems to be mediated predominantly by oxidation of tetrahydrobiopterin (BH4), an eNOS required cofactor. To study how these phenomena regulate the physiological balance of reactive oxygen species (ROS), H2O2-induced NO??oduction was measured in bovine aortic endothelial cells (BAECs) using an NO??ecific electrode. Following H2O2 exposure, NO??ncentrations initially increased; however, if cells were challenged a second time with H2O2, the increase in NO??oduction was attenuated. We postulated that the decline in NO??oduction after H2O2 exposure resulted from BH4 oxidation and tested this by supplementing cells with BH4 prior to the second H2O2 exposure. This resulted in a recovery of NO??oduction. Since H2O2 also activates NADPH oxidase to produce superoxide (O2?? we tested whether the decrease in NO??oduction during the second H2O2 exposure could be explained by increased NADPH oxidase-dependent oxygen free radical production, including O2??peroxynitrite (ONOO-), and hydroxyl radicals (??. A reduction in H2O2-induced NO??lease was prevented in apocynin-and PEG-SOD-treated cells and in p47phox-knockout mouse aortic endothelial cells (MAECs), which lack a critical subunit of the NADPH oxidase. These results suggest that O2??roduced by NADPH oxidase leads to eNOS dysfunction. Scavenging ONOO- resulted in a full recovery of NO??oduction, and scavenging ??resulted in a partial recovery of NO??oduction. This implies roles for these O2??erivatives in the reduced NO??sponse to repeated H2O2 exposures.

Primary cultured astrocytes were treated with Mn in the absence and presence of proinflammatory cytokines to determine their effect upon stimulation of nitric oxide (NO) production. Treatments of manganese and cytokines raised NO production to intermediate levels, whereas combined treatment raised NO creation to much greater levels. Furthermore, this combined treatment differed from control only in its ability to elevate cellular NO levels at 24 hours, but not at earlier time points. Combined exposure in astrocytes derived from mice lacking the nos2 gene prevented any increase in production of NO. Thus, manganese and cytokines enhance NO production through activation of the nos2 gene. Additionally, pharmacologic ligands of the peroxisome proliferator-activated receptor gamma (PPARγ) were used to test the role of this orphan nuclear receptor in modulating Mn-dependent production of NO. The agonist, 1,1-Bis(3’-indolyl)-1-(p-trifluormethylphenyl) methane (cDIM1) diminished NO in a dose-dependent manner, whereas addition of the PPARγ antagonist, GW 9662, amplified cellular NO production, also in a dose-dependent fashion. Moreover, it was observed that NO production was both attenuated and augmented at similar rates, suggesting the agonist and antagonist work through similar mechanisms. To clarify the means by which NO levels are manipulated by PPARγ, we measured activation levels of the transcription factor NF-κB, a primary factor resulting in expression of NOS2. We found that NF-κB was slightly activated in cells treated solely with manganese or cytokines, whereas cells treated with both manganese and cytokines showed the highest levels of activation. Also, we found that these ligands function through an NF-κB dependent mechanism. Treatment of cDIM1 to astrocytes already treated with manganese and cytokines caused decreased activation of NF-κB, while addition of GW9662 to similarly treated cells resulted in increased activation of NF-κB. While these compounds were effective at manipulating induction of the nos2 gene, they had no effect on induction of guanosine tri-phosphate cyclohydrolase (GTPCH) the rate limiting enzyme for the production of tetrahydrobiopterin (BH4), a cofactor essential to the conversion of arginine to NO, Thus, these novel PPARγ ligands can influence manganese- and cytokine-induced production of NO by an NF-κB dependent mechanism.

Recent studies suggest that carbon monoxide (CO) is another gas molecule that has similar biological actions as nitric oxide (NO). The purpose of this study is to investigate the relationship between NO and CO in the survival of naïve rat pheochromocytoma PC12 cells. Western blot analysis revealed that all three isoforms of nitric oxide synthase (NOS) exhibited low expression and two isoforms of heme oxygenase (HO), especially HO-1, exhibited higher expression in PC12 cells under basal condition. Exposure of PC12 cells for 24 h to the NO scavenger, carboxy-2-phenyl-4,4,5,5,- tetramethylimidazoline-1-oxy-1-3-oxide (carboxy-PTIO, 2 £gmol) or HO inhibitor, zinc protoporphyrinIX (ZnPP, 25 nmol) resulted in a progressive reduction in mitochondria dehydrogenase activity reflected cell viability as determined by the WST-1 (4-[3-(4-lodophenyl)- 2-(4-nitrophenyl)-2H-5-tetrazolio]-1,3-benzene disulfonate) assay. On the other hand, incubation with NO donors, amino-3-morpholinyl- 1,2,3-oxadiazolium chloride (SIN-1, 1 £gmol) or S-Nitroso-N-acetyl- penicillamine (SNAP, 1 £gmol), or the CO precursor, hematin (500 nmol), resulted in an elevation in cell viability. The progressive reduction in cell viability induced by carboxy-PTIO (2 £gmol) or ZnPP (25 nmol) was significantly blunted by co-treatment with SIN-1 (1 £gmol). However, incubation with the NO precursor, L-arginine (L-Arg, 2 £gmol), or the selective inhibitors for nNOS, iNOS or eNOS, N£s-propyl-L-arginine (NPLA, 100 pmol), S-methylisothiourea (SMT, 10 nmol) or N5-1-Iminoethyl-L-ornithine dihydrochloride (L-NIO, 4 nmol) did not significantly alter cell viability. Co-treatment with carboxy-PTIO (2 £gmol) and L-Arg (2 £gmol) was also ineffective. These results suggest that NO or CO contributes to the survival of naïve PC12 cells.

The objectives of this study were to 1) determine the effects of cycle-to-cycle variations (ccv) on nitric oxide (NO) emissions, and 2) determine if the consideration of ccv affects the average NO emission as compared to the mean cycle NO emission. To carry out the proposed study, an engine simulation model was used. The simulation determines engine performance and NO emissions as functions of engine operating conditions, engine design parameters, and combustion parameters. An automotive, spark-ignition engine at part load and 1400 rpm was examined in this study. The engine cycle simulation employed three zones for the combustion process: (1) unburned gas, (2) adiabatic core region, and (3) boundary-layer gas. The use of the adiabatic core region has been shown to be especially necessary to capture the production of nitric oxides which are highly temperature dependent. Past research has shown that cyclic variations in combustion cause ccv of burn duration, ignition delay and equivalence ratio. Furthermore, literature has shown that variations of these three input parameters may be approximated by a normal frequency distribution. Using the mean and standard deviation, and a random number generator, input values were tabulated for the ignition delay, burn duration and equivalence ratio. These three input parameters were then used to simulate cyclic variations in the combustion process. Calculated results show that cyclic variations of the input parameters cause the cycle-by-cycle NO emissions to increase and decrease by as much as 59% from the mean cycle NO of 3,247 ppm. The average NO emission resulting from ccv was 4.9% less than the mean cycle NO emission. This result indicates that cyclic variations must be considered when calculating the overall NO emissions.

Thesis (M. Phil.)--University of Hong Kong, 2009. / Includes bibliographical references (leaves 73-90). Also available in print.

published_or_final_version / Chemistry / Doctoral / Doctor of Philosophy

published_or_final_version / Pharmacology and Pharmacy / Master / Master of Medical Sciences

Background and objectives: Circulating endothelial progenitor cells (EPCs) play an essential role in maintaining vascular integrity and preventing endothelial dysfunction. Decreased circulating EPC levels are frequently observed in various cardiovascular risks, including aging and diabetes. Endothelial nitric oxide synthase (eNOS) and adiponectin exert their vasculo-protective effects by directly targeting the key components of the vascular system, such as endothelial cells and smooth muscle cells. Both eNOS and adiponectin have been implicated in the mobilization and in vitro functions of EPCs. However, whether and how circulating EPCs are involved in eNOS and adiponectin-mediated vascular protection remain unclear. The objective of this study is to investigate the role of circulating EPCs in eNOS and adiponectin-mediated regulation of vascular integrity after arterial injury under both physiological and pathophysiological conditions, and to elucidate the underlying mechanisms involved. Key findings: 1. Modulation of eNOS activity in vivo by replacing the serine 1176 (S1176) with an aspartate (S1176D mutation or Dki) to mimic phosphorylation or with an alanine (S1176A mutation or Aki) to render it unphosphorylatable altered reendothelialization and subsequent endothelial function after arterial injury in mice. 2. eNOS S1176D mutation increased the number of circulating EPCs and their incorporation into regenerated endothelium, whereas eNOS S1176A or knockout (KO) impaired the mobilization and reendothelializing capacity of circulating EPCs after injury. 3. eNOS S1176D elevated circulating EPCs by promoting the proliferation and differentiation of bone marrow hematopoietic stem cells (HSCs) into EPCs and by inhibiting apoptosis of circulating EPCs. 4. Adiponectin deficiency in mice resulted in progressive decrease of circulating EPCs with aging. Systemic administration of recombinant adiponectin reversed the decreased EPCs number in adiponectin KO mice. In db(-/-) diabetic mice, adiponectin deficiency further reduced circulating EPCs number and subsequent reendothelialization after injury. Rosiglitazone (Rosi), an antidiabetic drug, induced an upregulation of EPCs number and improved reendothelialization, which were partially abolished in the absence of adiponectin. 5. In cultured EPCs, adiponectin significantly inhibited high glucose-induced premature senescence, whereas its effects on proliferation and apoptosis were not evident. High glucose instigated EPCs senescence by increasing the intracellular accumulation of reactive oxygen species (ROS), activation of p38 MAPK and expression of p16INK4A, whereas all these changes could be abolished by adiponectin through adenosine monophosphate (AMP)-activated protein kinase (AMPK) and cyclic AMP (cAMP)/protein kinase A (PKA)-dependent pathways. 6. Compared to cells from db(-/-) diabetic mice, bone marrow EPCs isolated from db(-/-) plus adiponectin double KO (DKO) mice were more susceptible to high glucose-evoked senescence, which were abrogated by adiponectin in vitro. Importantly, chronic administration of adiponectin or the anti-oxidant N-acetylcysteine (NAC) prevented both aging and diabetes-associated elevation of p16INK4A and decline of circulating EPCs in DKO mice. Conclusions: Collectively, the current study demonstrates that circulating EPCs are actively involved in the vasculo-protective effects of both eNOS and adiponectin under physiological and pathological conditions. These findings enrich our knowledge of the versatile functions of eNOS and adiponectin in vascular protection and provide solid scientific evidence supporting the use of eNOS and adiponectin as possible therapeutic targets for cardiovascular diseases. / published_or_final_version / Medicine / Doctoral / Doctor of Philosophy

Background Nitric oxide (NO) and endothelium-derived hyperpolarizing factor (EDHF) are both important relaxing factors. Their synthesis, release and downstream signaling pathways are controlled by a number of proteins, such that alteration in the activity of these proteins may disturb vascular tone. Aim This study was aimed to investigate the role of some of the regulatory proteins in NO- and EDHF-mediated relaxations. The regulatory proteins that were examined include: 1) calcium-calmodulin dependent protein kinase II (CaMK II), 2) mitogen-activated protein kinase (MAPK), 3) adenosine monophosphate-activated protein kinase (AMPK), 4) phosphoinositide 3-kinase (PI3K) / protein kinase B (Akt) and 5) phosphoprotein phosphatase. Experimental approach Organ chamber system was used for measuring isometric tension of porcine coronary arteries. The role of the regulatory proteins was investigated by using their activators or inhibitors. In the contraction study, arterial rings without endothelium were contracted with U46619 (0.1 nM to 10 μM) or phorbol 12,13-dibutyrate (PDBu, 0.1 nM to 1 μM). In the relaxation study, arterial rings with and without endothelium were contracted with U46619 (30 or 100 nM). They were incubated with indomethacin (cyclooxygenase inhibitor, 10 μM) and TRAM-34 plus UCL1684 (intermediate- and small-conductance calcium-activated potassium channel blockers, respectively; 1 μM each) or L-NAME (NO synthase inhibitor, 30 μM) for the study of NO and EDHF components of bradykinin (0.1 nM to 10 μM)-induced relaxations. Moreover, endothelium-independent relaxations by sodium nitroprusside (SNP, exogenous NO donor, 0.1 nM to 100 μM) and diazoxide (ATP-sensitive potassium channel activator, 1 nM to 1 mM) were examined in arteries without endothelium. Key findings 1. NO and EDHF are both involved in endothelium-dependent relaxation in porcine coronary arteries, in which NO is the dominant relaxing factor. 2. KN-93 (CaMK II inhibitor, 30 μM) significantly reduced contractions to U46619 and PDBu. On the other hand, CaMK II partly involved in EDHF signaling but not in the NO-mediated relaxations. 3. Calyculin A (phosphoprotein phosphatase inhibitor, 30 nM) greatly inhibited both endothelium-dependent and –independent relaxations. 4. PD98059 (MAPK inhibitor, 30 μM) significantly potentiated bradykinin-induced relaxation that was mediated by EDHF but not that mediated by NO. On the other hand, it potentiated SNP-induced but not diazoxide-induced endothelium-independent relaxations. 5. AMPK and Akt do not play a role in regulating vascular tone as compound C (AMPK inhibitor, 30 μM), AICAR (AMPK activator, 1 mM) and wortmannin (PI3K inhibitor, 100 nM) did not affect contractions to U46619 and PDBu, and relaxations to bradykinin, SNP and diazoxide in porcine coronary arteries. Conclusions and implications Different regulatory proteins (CaMKII, MAPK, AMPK, Akt, phosphoprotein phosphatase) have different effects on the regulation of vascular tone. While the present study has the limitation of using pharmacological agents at only one concentration to examine the role of these proteins, it still produces scientific information for the development of therapeutic agents. In considering CaMK II, MAPK and phosphoprotein phosphatase as potential therapeutic targets, the vascular effects (which can be therapeutic or adverse) of the compounds acting on these proteins should be taken into account. / published_or_final_version / Pharmacology and Pharmacy / Master / Master of Medical Sciences

Nitrifier denitrification is a poorly quantified microbial process leading to emissions of N2O from soils. Nitrous oxide emissions, particularly from agricultural soils, are currently being targeted for reduction due to the contribution of this gas to anthropogenic climate change. Measurements specific to nitrifier-denitrification are hampered by poor culturability of many of the strains involved, and the inability of single isotope labelling methods to distinguish it from denitrification carried out by other organisms, dual-labelling approaches and evidence form pure cultures suggest that its contribution to nitrous oxide emissions may be large. Environmental conditions favouring the pathway are unknown, leading to difficulties in mitigation or modelling. In this thesis data from both dual-labelling isotopic techniques and isotopomer measurements of the nitrous oxide emitted are used to determine whether isotopomer techniques can quantify nitrifier-denitrification in situ, and the conditions under which nitrous oxide emissions from the pathway are increased are investigated. Data is also presented on site preference (isotopomer ratio) from ammonia oxidation in several Nitrosospira strains for which this has previously not been measured. The capacity of Nitrosospira strains in pure culture to reduce N2O to N2, an environmentally neutral product of the nitrogen cycle, are investigated. Site preference results from this research suggest that nitrifier denitrification cannot be distinguished from heterotrophic denitrification by site preference, indicating that previously published data stating proportional outputs of N2O from dentrification may overestimate heterotrophic contributions. Several Nitrosospira strains are found to be capable of a reduction step from N2O to N2 in pure culture conditions. Nitrifier denitrification is found to respond to environmental factors of soil N-level, pH and rainfall events, and changes in site preference also occur under these conditions. Site preference is linked to microbial phylogeny for the strains of Nitrosospira tested, indicating a possible effect of enzyme structure above pathway level determination.